A Clinical Study on the Effects of a Dietary Supplement on Stress, Anxiety, Mood and Sleep in a Pediatric Population

NCT07076537 · tracked via the Priya Life Science USA tracker

Sponsor

Olly, PBC

Phase

Not applicable

Started

2025-07-15

Last updated

2025-07-22

Condition(s) studied

Healthy

Investigational drug(s) / intervention(s)

PlaceboDietary Supplement with actives

Placebo: Placebo

Dietary Supplement with actives: Dietary Supplement containing magnesium, L-theanine and lemon balm extract

Study summary

The study will be a randomized, placebo control clinical study to assess the the efficacy for improvement of mood/stress and anxiety compared to placebo through validated survey questionnaire. The target population of this study is 5 to 14 years old. Participants will be asked to take questionnaires to collect baseline at the beginning of the study. The questionnaires are: Perceived Stress Scale for children (PSS-ch), The Positive Affect and Negative Affect Schedule-Child Form-children (PANAS-children) and the Children's Sleep Habits Questionnaire (CSHQ). The interventional treatment will be for a total of 4 weeks (28 days). Participants will be asked to take the questionnaires at the end of the 28 days. The subjects will attend two appointments in the clinic throughout the duration of the study.

Eligibility

Sex

ALL

Min age

5 Years

Max age

14 Years

Healthy volunteers

Accepted

Inclusion Criteria: 1. Willingness to actively participate in the study and to come to the scheduled visits. 2. Healthy (Healthy as determined by medical history as assessed by Qualified Investigator ) female and male subjects in good health between 5 to 14 years old. 3. Enrolled in and currently attending school at baseline and for the duration of the study period. 4. Agreement to adhere to the procedures and requirements of the study and to report to the institute on the day(s) and at the time(s) scheduled for the assessments. 5. Ability to give consent (assent) for participation in the study Exclusion Criteria: 1. Diagnosed with any mental health condition including chronic stress, GAD, impaired cerebral function, mood disorders, ADHD or similar conditions 2. Currently taking any prescription medications or dietary supplements for sleep, anxiety, depression or ADHD 3. Liver dysfunction 4. Use of sleep aides including dietary supplements over the past 7 days 5. History of reaction to the category of product tested 6. Other diseases or medications that might directly interfere in the study or put the subject's health under risk. 7. Participants having an acute or chronic disease or medical condition could put him/her at risk in the opinion of the Principal Investigator or compromise study outcomes. 8. Typical uncontrolled chronic or serious disease and/or conditions which would prevent participation in any clinical trials such as cancer, AIDs, diabetes, renal- impairment, mental illness, drug/alcohol addiction. 9. Subjects with a history of cancer within the past 5 years. 10. Subjects with any planned surgeries and/or invasive medical procedures during the study. 11. Individuals unable to communicate or cooperate with the principal investigator due to language 12. Employees (and children of employees) of TKL and/or product brand owner or manufacturer.

Primary outcome measure(s)

To assess the efficacy for improvement of feelings of stress compared to placebo through validated survey questionnaire. — from enrollment to end of study at Week 4
PSS-children will be administered before the intervention to establish baseline, 40 min after taking the initial dose and after taking the product for 28 days consecutively. Scores will be analyzed to assess changes in improvement in stress levels across the active and placebo arms. Data will be compared between the active supplement and placebo groups. More details on the scales The PSS-C: (perceived stress scale -children form) Scoring range: Each item is scored from 0 (Never) to 4 (Very Often), giving a total score range from 0 to 56. Interpretation: Higher scores indicate higher perceived stress, meaning a worse outcome.

Trial sites (1)

Facility	City	Region	Status
TKL Research	Fair Lawn	New Jersey

More Olly, PBC trials in the USA

A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS). Recruiting

A Randomized, Placebo Controlled Clinical Study to Assess the Effect of a Blend of Digestive Enzymes and Extracts on Bloating in Adults. Starting soon

Clinical Study to Assess the Effects of Prebiotic and Probiotic Supplement Active, not recruiting

A Randomized Double Blind, Placebo Controlled Clinical Study Evaluating the Efficacy and Safety of Magnesium Supplementation on Relaxation in Adults Starting soon

Other trials for the same condition

Study of Student Flourishing Recruiting

Vitamin and Mineral Absorption From Milk and PBMAs Active, not recruiting

A Study of V118E in Healthy Participants (V118E-003) Active, not recruiting

A Study to Learn About the Single Dose Pharmacokinetics of Study Medicine Called Tilrekimig in Healthy Adults When Co-Mixed With rHuPH20 Active, not recruiting

A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS). Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07076537 on ClinicalTrials.gov ↗ ← All trials in the USA